Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

C3_STOMACH_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C16 Hospital discharge: ICD-9 — 151 Hospital discharge: ICD-8 — 151 Cause of death: ICD-10 — C16 Cause of death: ICD-9 — 151 Cause of death: ICD-8 — 151 Cancer registry: Topography ICD-O-3 — C16 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2384
4. Check minimum number of events None	2384
5. Include endpoints None	2384
6. Filter based on genotype QC (FinnGen only)	2384

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_STOMACH_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C16
HD_ICD_9	151
HD_ICD_8	151
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C16
COD_ICD_9	151
COD_ICD_8	151
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C16
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2384	807	1577
Unadjusted period prevalence (%)	0.55	0.28	0.70
Median age at first event (years)	68.36	66.57	69.27

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1822: Matched controls
18212

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

2133.0

323.0

336

A04AA02

ATC

granisetron; systemic, transdermal

1376.2

323.0

424

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2051.9

323.0

327

B03BA03

ATC

hydroxocobalamin; parenteral

15.8

323.0

665

640

107

Kela drug reimbursment

Pernicious anaemia

40.8

323.0

522

177

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

331.4

323.0

327

H02AB02

ATC

dexamethasone; systemic

107.0

323.0

538

L01BC06

ATC

capecitabine; oral

+∞

323.0

417

A03FA01

ATC

metoclopramide; systemic, rectal

18.4

323.0

918

952

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

893

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

11.8

323.0

1318

3298

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

8262.5

323.0

584

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

299.4

279

C16.00

ICD-10 Finland

Cardia

+∞

287.2

268

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

169.9

277.8

287

JN4BD

NOMESCO Finland

Extensive body CT

15.7

275.1

477

401

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

272.9

255

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

253.1

237

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

246.5

231

WX302

NOMESCO Finland

Thoracal epidural anesthesy

30.3

233.4

318

126

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

221.4

208

B81

ICPC

Anaemia vit B12/folate deficiency

14.1

219.0

395

350

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

211.6

199

Z51.5

ICD-10 Finland

Palliative care

20.8

209.6

321

185

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

208.4

196

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

199.7

188

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

195.3

184

A04AA01

ATC

ondansetron; systemic, rectal

26.2

186.3

264

117

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

181.3

171

N02AA05

ATC

oxycodone; systemic

6.3

174.8

539

1143

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

168.3

159

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

449.5

167.4

165

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

166.2

157

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

160.8

152

JN4AD

NOMESCO Finland

Body CT examination

13.6

157.2

285

245

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

142.6

135

R4190

NOMESCO Finland

Nutritional therapy

23.3

142.1

208

100

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

138.3

131

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

130.8

124

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

129.7

123

L03AA02

ATC

filgrastim; parenteral

170.3

122.0

127

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

120.1

114

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

10.5

119.8

246

267

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

25.6

119.7

170

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

135.1

118.7

126

JN4CD

NOMESCO Finland

Very extensive body CT

20.2

116.2

178

L03AA13

ATC

pegfilgrastim; parenteral

+∞

115.8

110

C61

ICD-10 Finland

Malignant neoplasm of prostate

401.6

114.8

114

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

112.6

107

A04AA55

ATC

palonosetron, combinations; systemic

+∞

112.6

107

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

10.6

110.8

225

238

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

110.5

105

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

108.4

103

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.6

108.1

622

2302

JAH01

NOMESCO Finland

Laparoscopy

14.3

106.9

187

144

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

105.2

100

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

21.0

104.7

158

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

104.1

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

100.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.0

98.7

263

431

TPX10

NOMESCO Finland

Implantation of vascular injection port

15.0

98.2

168

122

A02BC02

ATC

pantoprazole; systemic

2.9

97.4

1293

8270

WZC30

NOMESCO Finland

Teaching

5.2

96.3

328

731

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

94.6

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

329.1

92.7

A04AD12

ATC

aprepitant; systemic

+∞

90.3

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

59.1

90.2

106

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

123.7

87.8

B01AB05

ATC

enoxaparin; parenteral

3.0

85.9

652

2854

WF049

NOMESCO Finland

Radiotherapy of metastasis

225.3

84.1

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

80.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

80.8

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

+∞

80.8

D74

ICPC

Malignant neoplasm stomach

+∞

78.7

WW500

NOMESCO Finland

Blood transfusion

10.6

78.7

158

161

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

+∞

76.6

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

393.1

76.3

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

38.9

75.6

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

73.4

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

+∞

72.3

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

71.3

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

71.3

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

70.2

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

70.2

UJD02

NOMESCO Finland

Gastroscopy

5.4

69.8

224

457

WX600

NOMESCO Finland

Single shot through catheter

45.0

69.8

WX402

NOMESCO Finland

General anaesthesia

3.8

68.0

322

968

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

10.5

66.7

134

136

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

66.0

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.3

65.9

166

246

JAH00

NOMESCO Finland

Laparotomy

9.8

65.7

137

149

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

65.0

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

14.3

64.7

112

116

Kela drug reimbursment

Prostate cancer

+∞

63.9

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

639.1

63.2

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

329.0

62.8

WF004

NOMESCO Finland

Palliative radiotherapy

628.4

62.2

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

61.8

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

617.7

61.1

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

60.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.7

60.7

503

2234

XX3DW

NOMESCO Finland

Time consuming IT work

5.9

59.9

178

329

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.9

59.0

270

782

ZX120

NOMESCO Finland

Intravenous

4.3

58.8

239

621

WF002

NOMESCO Finland

Radical radiotherapy

84.2

58.3

TPH07

NOMESCO Finland

Cathetrisation of artery

3.8

58.1

276

825

8480/3-C16.9

ICD-O-3

Mucinous adenocarcinoma of stomach, NOS

+∞

57.6

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

8.7

57.5

128

156

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

82.9

57.3

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

21.4

56.6

L01BC53

ATC

tegafur, combinations; systemic

+∞

56.5

C16.21

ICD-10 Finland

Malignant tumor of the corpus ventriculi early diffuse gastric carcinoma

+∞

56.5

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

56.5

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

199.4

56.3

6322

FHL

Gastrectomy (including Roux-Y)

553.7

54.8

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

48.0

53.6

B01AB10

ATC

tinzaparin; parenteral

5.5

53.3

166

324

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

52.3

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

19.0

51.8

8145/3-C16.0

ICD-O-3

Carcinoma, diffuse type of cardia, NOS

+∞

51.3

K29.4

ICD-10 Finland

Chronic atrophic gastritis

7.0

50.8

131

200

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

50.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

9.4

49.9

106

119

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

48.0

448

2086

JDA63

NOMESCO Finland

Local excision of lesion of stomach

131.0

48.0

JMA10

NOMESCO Finland

Transabdominal total splenectomy

57.7

47.7

8140/3-C16.3

ICD-O-3

Adenocarcinoma, NOS, of gastric antrum

+∞

47.1

C16.5

ICD-10 Finland

Malignant neoplasm: Lesser curvature of stomach, unspecified

+∞

47.1

UJC12

NOMESCO Finland

Flexible oesophagoscopy

18.1

44.8

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

43.9

8240/3-C16.2

ICD-O-3

Neuroendocrine tumor, NOS, of body of stomach

+∞

43.9

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

19.8

42.9

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

42.9

C16.31

ICD-10 Finland

Malignant tumor of the antrum ventriculi early diffuse gastric carcinoma

+∞

42.9

8144/3-C16.2

ICD-O-3

Adenocarcinoma, intestinal type of body of stomach

+∞

42.9

8145/3-C16.3

ICD-O-3

Carcinoma, diffuse type of gastric antrum

+∞

42.9

JDW97

NOMESCO Finland

Other laparoscopic operation on stomach or duodenum

426.8

42.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

41.8

WF003

NOMESCO Finland

Adjuvant radiotherapy

416.3

41.3

JKA20

NOMESCO Finland

Cholecystectomy

5.5

41.2

127

244

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.4

40.8

215

689

D70.82

ICD-10 Finland

Drug-induced neutropenia

40.3

40.8

A79

ICPC

Malignancy NOS

+∞

40.8

L02AE02

ATC

leuprorelin; implant, parenteral

90.1

39.9

8144/3-C16.3

ICD-O-3

Adenocarcinoma, intestinal type of gastric antrum

+∞

39.7

R11

ICD-10 Finland

Nausea and vomiting

3.5

39.6

200

620

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

395.4

39.2

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

75.2

39.0

D64.9

ICD-10 Finland

Anaemia, unspecified

2.7

38.7

290

1178

115

Kela drug reimbursment

Breast cancer

+∞

38.7

B03BA02

ATC

cyanocobalamin tannin complex; parenteral

15.5

38.1

C16.02

ICD-10 Finland

Malignant tumor of cardiac early intestinal gastric carcinoma

+∞

37.6

189

Kela drug reimbursment

Imatinib

+∞

37.6

JDC11

NOMESCO Finland

Laparoscopic partial gastrectomy and gastrojejunostomy

+∞

36.6

9699/3-C16.9

ICD-O-3

Marginal zone B-cell lymphoma, NOS, of stomach, NOS

+∞

36.6

A06AH03

ATC

naloxegol; oral

30.7

36.2

9591/3-C16.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of stomach, NOS

+∞

35.5

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

+∞

35.5

ZX090

NOMESCO Finland

Other technic of radiotherapy

68.0

35.1

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

10.8

34.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

34.5

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

34.5

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

34.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

33.4

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

33.1

368

1832

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

32.7

781

5255

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

40.9

32.2

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

5.4

31.6

190

R13

ICD-10 Finland

Dysphagia

3.4

31.3

163

515

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

4.6

31.3

112

254

A09AA02

ATC

multienzymes (lipase, protease etc.)

7.8

31.2

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

317.8

30.9

PJA12

NOMESCO Finland

Sentinel node biopsy

86.6

30.8

K92.1

ICD-10 Finland

Melaena

3.2

30.7

171

566

C16.22

ICD-10 Finland

Malignant tumor of the corpus ventriculi early intestinal gastric carcinoma

+∞

30.3

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

30.0

249

1064

ZX070

NOMESCO Finland

Intensity modified radiotherapy

307.0

29.9

D77

ICPC

Malignant digestive neopl other/NOS

+∞

29.2

C16.32

ICD-10 Finland

Malignant tumor of the antrum ventriculi early intestinal gastric carcinoma

+∞

29.2

JFF00

NOMESCO Finland

Catheter enterostomy

+∞

29.2

C16.6

ICD-10 Finland

Malignant neoplasm: Greater curvature of stomach, unspecified

+∞

29.2

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

11.3

29.1

K92.0

ICD-10 Finland

Haematemesis

4.6

29.0

105

241

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

152.3

28.7

R18

ICD-10 Finland

Ascites

7.7

28.4

C16.19

ICD-10 Finland

Malignant tumor of the fundus ventriculi other or unspecified carcinoma

+∞

28.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

28.2

8140/3-C16.2

ICD-O-3

Adenocarcinoma, NOS, of body of stomach

+∞

28.2

B01AB04

ATC

dalteparin; parenteral

3.8

27.7

121

331

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

27.6

253

1136

K22.2

ICD-10 Finland

Oesophageal obstruction

10.5

27.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

27.2

558

3510

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

27.1

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

27.1

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

27.1

L01XE01

ATC

[U] imatinib; oral

+∞

27.1

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

6.2

27.1

123

R50.9

ICD-10 Finland

Fever, unspecified

2.3

26.4

262

1221

N02AX02

ATC

tramadol; systemic, rectal

1.7

26.3

735

5094

8000/3-C16.9

ICD-O-3

Neoplasm, malignant of stomach, NOS

+∞

26.1

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

264.0

25.7

JDC97

NOMESCO Finland

Laparoscopic partial gastrectomy with other reconstruction

264.0

25.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

264.0

25.7

K91.1

ICD-10 Finland

Postgastric surgery syndromes

50.7

25.3

RD210

NOMESCO Finland

8.4

24.4

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

49.0

24.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

24.2

161

600

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

24.0

282

1421

C16.1

ICD-10 Finland

Malignant neoplasm: Fundus of stomach

+∞

24.0

C16.10

ICD-10 Finland

Malignant tumor of the fundus ventriculi without histology

+∞

24.0

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

24.0

L01EA01

ATC

imatinib; oral (bcr-abl tyrosine kinase inhibitors)

+∞

24.0

L02BB03

ATC

bicalutamide; oral

+∞

24.0

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

8.1

24.0

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

8.2

23.7

UJF32

NOMESCO Finland

Coloscopy

1.9

23.6

437

2627

JDE00

NOMESCO Finland

Gastrojejunostomy

126.6

23.6

J01MA12

ATC

levofloxacin; systemic

2.0

23.3

362

2044

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

8.7

23.1

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

23.0

Y77

ICPC

Malignant neoplasm prostate

+∞

23.0

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

23.0

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

22.6

127

421

ZX112

NOMESCO Finland

Subcutaneous

12.7

22.6

376

Kela drug reimbursment

Cyanocobalamin

121.4

22.6

TPX15

NOMESCO Finland

Removal of vascular injection port

32.7

22.4

JN3AD

NOMESCO Finland

Abdominal CT examination

2.8

22.4

148

550

ZXC86

NOMESCO Finland

Use of endoscopic device

15.9

22.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

8.5

21.9

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

21.9

JDD96

NOMESCO Finland

Total gastrectomy with other reconstruction

+∞

21.9

C16.14

ICD-10 Finland

Malignant tumor of the fundus ventriculi intestinal carcinoma

+∞

21.9

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

21.9

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

21.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

21.9

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

9.4

21.8

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.7

21.5

269

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

43.8

21.4

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

14.1

21.3

JFF01

NOMESCO Finland

Laparoscopic catheter enterostomy

+∞

20.9

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

20.9

D00.2

ICD-10 Finland

Carcinoma in situ: Stomach

+∞

20.9

R4110

NOMESCO Finland

Physiotherapy

1.8

20.8

425

2626

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

20.8

264

1371

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.7

20.8

261

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

212.1

20.6

T91

ICPC

Vitamin/nutritional deficiency

9.3

19.9

316

Kela drug reimbursment

Imatinib

+∞

19.8

8010/3-C16.9

ICD-O-3

Carcinoma, NOS, of stomach, NOS

+∞

19.8

C16.13

ICD-10 Finland

Malignant tumor of the fundus ventriculi diffuse carcinoma

+∞

19.8

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

19.8

NK6AN

NOMESCO Finland

Total body bone isotope imaging

29.3

19.6

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

4.3

19.6

174

A02BC05

ATC

esomeprazole; systemic

1.6

19.4

644

4577

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

7.7

19.1

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.8

18.8

1514C

ICD-9 Finland

Malignant neoplasm of stomach, Body of stomach[MAHASYÖPÄ, CORPORIS DIFFUUSI KARSINOOMA]

+∞

18.8

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

+∞

18.8

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

383

188

24.07

307.65

4.4

1.8

u/ml

298.3

103.2

1.35

353

171

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1005

953

17.50

307.65

5.8

1.4

ug/l

27.8

4.1

4.39

905

721

(40768797) Stomach Pathology biopsy report

901

2197

5.98

307.65

2.1

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

685

1263

7.20

307.65

3.3

1.9

g/l

0.2

1.25

659

1129

(4035726)

550

455

15.41

307.65

1.7

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

553

341

20.81

307.65

5.3

1.7

u/ml

774.1

48.1

1.24

502

271

(3012095) Magnesium [Moles/volume] in Serum or Plasma

747

2516

3.87

187.58

4.2

2.4

mmol/l

0.8

2.38

720

2286

(3024561) Albumin [Mass/volume] in Serum or Plasma

1357

7235

3.03

151.98

10.1

3.7

g/l

32.4

35.0

46.24

1307

6576

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1457

8163

3.02

147.48

14.2

3.7

umol/l

11.2

12.4

3.75

1423

7609

(3044640) Blood type and Crossmatch panel - Blood

964

4653

2.80

123.46

3.8

2.2

—

(3002256) Pathology report gross observation

387

1132

3.89

114.70

1.5

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

579

2252

3.07

108.68

5.0

4.9

mmol/l

1.0

2.96

557

2047

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1009

5244

2.60

108.20

3.5

2.3

u/l

59.8

0.01

951

4800

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

469

1638

3.32

105.39

4.0

2.2

umol/l

9.1

8.4

0.26

427

1414

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1214

7015

2.49

102.12

5.7

3.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

759

3583

2.64

97.32

3.5

2.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

554

2230

2.93

96.65

10.2

5.7

mmol/l

104.8

104.2

2.11

544

2165

(3032080) INR in Blood by Coagulation assay

1249

7535

2.38

92.38

9.1

11.1

inr

1.2

1.4

7.34

325

2092

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

881

4655

2.41

86.93

2.6

2.2

mg/l

3.4

3.0

4.56

793

3891

(3023368) Bacteria identified in Blood by Culture

930

5092

2.35

83.98

5.4

3.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

615

2789

2.62

83.87

2.5

2.4

umol/l

10.8

12.7

6.56

579

2543

(40768804) Tissue Pathology biopsy report

882

4765

2.35

81.67

2.8

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

374

1323

3.17

80.89

4.7

2.1

u/l

39.0

38.4

0.05

340

1098

(3013650) Neutrophils [#/volume] in Blood by Automated count

1343

8730

2.23

78.42

15.6

6.1

e9/l

4.2

4.5

2.59

1210

7452

(3004789) Transferrin [Mass/volume] in Serum or Plasma

558

2560

2.54

73.13

2.3

2.4

g/l

2.4

2.3

6.39

524

2348

(3015377) Calcium [Moles/volume] in Serum or Plasma

933

5371

2.21

72.16

6.3

2.1

mmol/l

2.3

8.04

873

4417

(3033658) Prothrombin time (PT) actual/Normal

730

3852

2.29

69.34

6.1

3.5

83.6

82.7

0.44

722

3737

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

522

2381

2.53

68.83

2.3

2.5

18.4

22.4

5.94

441

2001

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

620

3176

2.29

62.21

6.5

2.2

mmol/l

2.5

2.4

3.15

583

2701

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

824

4754

2.12

61.16

5.0

2.5

u/l

40.8

40.3

0.04

799

4477

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

20.82

59.30

1.4

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1171

7768

2.00

58.34

8.6

5.0

mmol/l

1.2

5.74

1113

6830

(3000570) Elastase.pancreatic [Mass/mass] in Stool

166

428

4.09

57.55

1.7

1.5

ug/g

237.5

291.6

3.23

131

259

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1258

8594

1.98

57.16

9.7

5.5

mmol/l

1.2

8.77

1058

7172

(3020779) Urea [Moles/volume] in Serum or Plasma

378

1621

2.58

55.79

5.2

6.0

mmol/l

8.5

11.6

11.95

355

1524

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

256

897

3.08

55.39

10.5

8.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

304

1176

2.82

54.97

1.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

407

1825

2.48

54.59

3.9

2.6

u/l

231.6

237.7

0.46

384

1685

(4281824)

9.44

50.20

1.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

986

6504

1.88

46.76

3.4

2.8

ug/l

101.0

146.8

8.32

921

5885

(3002173) Hemoglobin [Mass/volume] in Arterial blood

371

1718

2.37

45.79

10.5

6.8

g/l

112.9

122.0

15.04

360

1658

(3018418) pH of Serum or Plasma

779

4927

1.86

40.90

5.7

3.2

7.4

0.18

181

887

(3016502) Oxygen saturation in Arterial blood

391

1936

2.22

40.88

10.1

6.3

96.1

94.9

3.84

377

1858

(3003396) Base excess in Arterial blood by calculation

412

2125

2.13

38.69

9.8

6.1

mmol/l

0.9

1.3

1.20

345

1615

(3027801) Oxygen [Partial pressure] in Arterial blood

414

2140

2.13

38.66

9.9

6.1

kpa

13.0

11.4

8.00

397

2031

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

414

2141

2.13

38.61

9.9

6.1

kpa

5.2

5.0

1.65

396

2032

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

173

599

3.03

37.90

2.4

2.6

u/ml

0.3

0.06

357

(3010370) Gastrin [Moles/volume] in Serum or Plasma

17.43

37.64

2.7

1.2

pmol/l

226.8

26.0

3.17

(3000991) Gas panel - Venous blood

309

1451

2.30

36.47

10.9

6.9

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1587

12624

1.77

36.15

16.1

5.3

u/l

101.8

77.5

23.09

1538

11591

(40758558) Short blood count panel - Blood

599

3631

1.87

35.06

11.9

4.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

319

1555

2.21

34.30

9.8

5.8

mmol/l

1.3

1.5

1.64

312

1483

(3013826) Glucose [Moles/volume] in Serum or Plasma

1339

10248

1.70

34.16

8.0

4.4

mmol/l

6.8

6.9

1.85

1303

9582

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1377

16664

0.59

33.49

4.4

5.4

mmol/l

2.4

2.6

9.56

1220

15119

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1335

16210

0.60

31.76

4.0

4.8

mmol/l

4.3

4.4

5.92

1188

14773

(42870588) Differential panel, method unspecified - Blood

790

5334

1.72

31.46

5.1

5.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1319

16046

0.60

31.36

3.9

4.7

mmol/l

1.4

1.81

1155

14508

(3027945) Reticulocytes/100 erythrocytes in Blood

408

2269

1.96

30.59

2.1

2.0

1.8

0.13

360

1953

(3042936) Bacteria identified in Isolate by Culture

419

2374

1.93

29.65

2.1

2.0

—

(3003694) ABO and Rh group [Type] in Blood

593

3753

1.77

29.36

1.3

—

(40768795) Lymph node Pathology biopsy report

9.28

27.40

1.2

1.1

—

(3019069) Monocytes/100 leukocytes in Blood

997

7352

1.61

27.14

5.8

5.7

9.3

8.9

2.45

952

6737

(3006504) Eosinophils/100 leukocytes in Blood

992

7330

1.60

26.62

5.5

5.4

2.5

3.0

9.67

946

6690

(3002030) Lymphocytes/100 leukocytes in Blood

1009

7487

1.60

26.60

5.8

5.6

23.6

26.1

9.23

957

6818

(3028717) Thiamine [Mass/volume] in Blood

17.07

26.35

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

8.40

26.14

1.6

2.6

e6/l

1159.8

389.8

0.77

(3022096) Basophils/100 leukocytes in Blood

965

7125

1.59

25.72

5.5

0.6

0.7

1.39

923

6513

(3004809) Band form neutrophils/100 leukocytes in Blood

208

3.79

24.97

2.4

2.8

2.0

1.5

0.51

151

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1299

15540

0.64

24.54

3.7

4.2

mmol/l

1.2

1.3

2.79

1133

13916

(3021960) Folate [Moles/volume] in Serum or Plasma

673

4609

1.64

24.12

1.8

1.6

nmol/l

22.1

19.9

3.14

608

3867

(3023520) Reticulocytes [#/volume] in Blood

310

1698

1.95

23.93

2.1

e9/l

66.0

67.5

0.28

226

1313

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

172

762

2.35

22.96

1.9

1.7

ug/l

2.9

1.8

0.52

154

651

(3019198) Lymphocytes [#/volume] in Blood

1044

8043

1.53

21.96

5.4

5.3

e9/l

1.7

1.8

6.23

910

6938

(3006315) Basophils [#/volume] in Blood

1029

7905

1.53

21.92

5.3

5.2

e9/l

0.0

0.85

881

6713

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

8.57

21.90

1.6

2.3

e6/l

9244.7

66679.5

—

(3033799) Differential panel - Peritoneal fluid

8.14

21.76

1.6

1.8

—

(3001604) Monocytes [#/volume] in Blood

1022

7850

1.53

21.73

5.3

5.2

e9/l

0.7

0.6

1.64

874

6655

(3018010) Neutrophils/100 leukocytes in Blood

971

7405

1.52

21.19

5.6

5.4

59.6

58.8

1.18

925

6786

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

120

474

2.61

20.48

1.7

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1347

15771

0.66

20.41

6.7

6.6

mmol/mol

41.0

41.1

0.21

1219

14398

(3044007) Cell count panel - Peritoneal fluid

8.47

20.14

1.7

2.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

130

4.15

19.66

1.6

1.5

u/ml

298.6

1070.0

0.33

124

(3013115) Eosinophils [#/volume] in Blood

1040

8176

1.48

18.90

5.7

5.3

e9/l

0.2

5.00

905

7050

(3018677) aPTT in Platelet poor plasma by Coagulation assay

430

2782

1.67

18.66

1.9

1.8

30.4

30.2

0.21

420

2683

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

209

1130

1.93

16.59

1.6

1.5

—

(40768441) Liver Pathology biopsy report

5.72

16.33

1.1

1.3

—

(3017181) Myelocytes/100 leukocytes in Blood

228

1281

1.86

16.08

3.2

3.7

1.1

0.9

0.74

113

283

(3002582) Erythrocytes [#/volume] in Urine

702

5235

1.48

15.97

3.5

3.1

e6/l

101.7

93.2

0.07

553

4039

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1294

14991

0.70

15.81

4.9

4.4

mu/l

2.0

2.1

1.01

1158

13376

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1440

16356

0.70

15.54

4.7

5.0

mmol/l

6.1

0.10

1296

14606

(1761868) Lipid panel - Serum or Plasma

331

4905

0.62

14.11

2.9

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

634

4733

1.46

14.02

3.5

3.0

e6/l

1.0

0.5

1.79

486

3589

(3021440) Promyelocytes/100 leukocytes in Blood

214

1234

1.81

13.85

3.1

3.8

0.1

0.05

103

262

(3002179) Metamyelocytes/100 leukocytes in Blood

205

1172

1.82

13.64

3.0

3.6

0.7

0.6

0.15

213

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

4.35

13.58

1.1

1.2

—

(3039000) Anion gap in Blood

403

2.39

13.56

7.0

5.9

mmol/l

11.1

11.3

0.13

367

(3018572) Chloride [Moles/volume] in Blood

403

2.39

13.56

7.0

5.9

mmol/l

105.6

105.3

0.21

367

(3002032) Base excess in Venous blood by calculation

286

1805

1.66

13.40

3.3

3.2

mmol/l

2.2

2.0

0.26

222

1424

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

233

1391

1.75

13.39

5.0

3.0

mmol/l

1.2

0.75

218

1173

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

442

3092

1.53

13.38

2.1

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

211

1243

1.76

12.69

1.3

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

387

2662

1.54

12.61

3.4

2.9

e6/l

2.5

2.1

0.24

221

1483

(3019060) Gas panel - Arterial blood

218

1301

1.74

12.53

5.5

4.3

—

(3022145) Colonoscopy Study observation

248

1536

1.69

12.46

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

162

886

1.89

12.41

1.4

1.5

g/l

1.5

0.28

145

740

(3047181) Lactate [Moles/volume] in Blood

118

579

2.09

12.30

6.4

5.4

mmol/l

1.6

1.3

0.88

104

516

(3026782) Osmolality of Urine

475

3430

1.48

12.23

3.0

2.6

mosm/kgh2o

549.3

555.1

0.24

422

2867

(40768806) Pleura Pathology biopsy report

170

3.04

12.04

1.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

281

1815

1.62

11.97

3.4

3.2

kpa

5.7

5.8

0.90

272

1738

(3008152) Bicarbonate [Moles/volume] in Arterial blood

210

1260

1.73

11.84

8.0

6.1

mmol/l

24.7

24.5

0.33

196

1181

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

371

2.34

11.81

2.0

2.1

g/l

3.8

3.5

0.77

349

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

112

550

2.09

11.67

1.3

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

559

4210

1.43

11.44

2.0

1.7

pmol/l

478.1

31737119.4

3.48

464

3403

(3017143) Hepatitis C virus Ab [Presence] in Serum

196

1167

1.74

11.36

1.3

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

549

4128

1.43

11.32

2.0

1.8

nmol/l

1180.5

1161.5

0.18

438

3062

(3021879) Hepatitis B virus core Ab [Presence] in Serum

133

703

1.94

11.30

1.2

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

441

3198

1.46

11.01

4.6

4.2

—

(36304419) Bacteria [Presence] in Urine

594

4552

1.41

10.95

3.5

3.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

148

820

1.86

10.91

5.7

4.2

1.6

0.02

136

782

(3007930) Methemoglobin/Hemoglobin.total in Blood

146

806

1.86

10.88

5.7

4.3

0.9

0.01

135

766

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

954

7914

1.34

10.62

2.4

2.1

pmol/l

83.4

92.5

9.39

641

4112

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

340

2.31

10.46

1.6

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

213

2.67

10.43

8.6

5.0

iu/ml

277.6

638.7

0.60

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

186

2.78

10.30

1.6

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.56

10.24

2.8

2.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

182

2.78

10.14

1.6

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

188

2.75

10.10

1.6

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

232

1490

1.62

10.08

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

2.92

9.97

3.7

2.3

u/ml

2567.2

422.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

313

2158

1.52

9.97

2.0

1.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

266

2.44

9.96

2.8

3.1

e9/l

4.2

4.6

0.70

266

(3025468) Yersinia sp identified in Specimen by Organism specific culture

184

2.75

9.94

1.6

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

2.75

9.94

1.6

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

190

2.72

9.91

1.6

1.2

—

(3018095) Leukocytes [#/volume] in Urine

743

6019

1.34

9.43

4.1

3.5

e6/l

161.2

122.4

0.27

564

4349

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

273

2.38

9.43

3.6

3.3

58.7

59.4

0.14

273

(3017354) Segmented neutrophils/100 leukocytes in Blood

145

2.93

9.39

2.1

2.9

57.7

58.6

0.07

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

196

2.64

9.34

1.1

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

309

2155

1.50

9.29

2.0

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

232

1521

1.58

9.25

3.1

2.7

kpa

4.3

4.5

0.32

223

1450

(3010421) pH of Blood

460

2.04

9.19

3.8

4.5

7.4

0.03

388

(3000963) Hemoglobin [Mass/volume] in Blood

1674

18102

0.75

9.19

45.7

21.2

g/l

120.2

135.5

239.29

1636

17680

(3026361) Erythrocytes [#/volume] in Blood

1674

18100

0.75

9.16

45.3

21.1

e12/l

4.1

4.5

118.57

1613

17357

(3035941) MCH [Entitic mass]

1674

18099

0.75

9.15

45.1

21.0

29.8

30.5

29.92

1640

17671

(3024731) MCV [Entitic volume]

1674

18098

0.75

9.13

45.2

21.0

90.9

91.7

7.49

1640

17669

(3007461) Platelets [#/volume] in Blood

1674

18095

0.75

9.09

45.4

21.0

e9/l

256.4

238.6

16.35

1622

17440

(3010813) Leukocytes [#/volume] in Blood

1675

18104

0.75

9.09

45.3

21.1

e9/l

7.2

6.9

2.39

1613

17366

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

503

1.97

8.77

1.7

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.44

8.77

1.1

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

160

973

1.69

8.61

2.3

2.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

204

1322

1.59

8.54

2.8

1.8

nmol/l

394.7

368.8

1.02

192

1177

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

526

6617

0.74

8.53

4.0

3.8

21.4

24.3

4.17

244

3274

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

413

2.05

8.43

1.3

1.4

—

(3025159) Blasts/100 leukocytes in Blood

184

1169

1.62

8.36

3.3

3.9

0.0

0.5

0.61

233

(3023199) Leukocytes [#/volume] in Pleural fluid

208

2.48

8.32

1.3

1.5

e6/l

1290.5

1409.6

0.15

148

(3026008) Bacteria identified in Urine by Culture

653

5274

1.33

8.26

3.2

3.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

678

8194

0.76

8.24

4.3

3.9

ug/l

3.6

2.7

0.47

590

7293

(3020682) Albumin/Creatinine [Ratio] in Urine

492

6222

0.74

8.20

3.7

4.0

mg/mmol

16.5

8.7

0.71

314

4015

(3020630) Protein [Mass/volume] in Serum or Plasma

227

1523

1.54

8.17

2.4

1.6

g/l

62.4

66.5

10.81

210

1347

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.14

7.99

1.5

2.7

—

(3012516) Albumin [Mass/volume] in Urine

460

5855

0.73

7.96

3.1

3.2

mg/l

635.1

207.7

0.85

300

3791

(3000850) Epithelial cells [#/volume] in Urine

475

3681

1.36

7.87

2.6

2.5

e6/l

5.0

4.8

0.22

421

3188

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

328

4391

0.71

7.73

1.7

1.6

mmol/l

1.3

1.02

280

3629

(3028308) Erythrocytes [#/volume] in Pleural fluid

186

2.50

7.66

1.3

1.5

e6/l

12222.0

72432.3

1.06

110

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

381

2867

1.39

7.55

3.3

2.7

e6/l

1.3

0.04

215

1677

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1064

12060

0.79

7.51

4.1

3.6

pmol/l

14.8

15.0

1.44

957

10710

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.91

7.43

1.5

2.6

12.4

15.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

116

2.87

7.21

1.4

1.5

—

(40768793) Breast Pathology biopsy report

3.40

6.97

1.1

—

(3012501) Base excess in Blood by calculation

396

1.95

6.85

4.1

4.7

mmol/l

2.7

2.8

0.12

264

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

785

6634

1.27

6.79

2.5

2.2

nmol/l

75.6

78.4

1.84

720

5745

(3009508) Creatinine [Moles/volume] in Urine

483

5984

0.76

6.73

3.0

3.2

mmol/l

7.3

7.5

0.36

382

4964

(3006653) Thiamine [Moles/volume] in Blood

3.16

6.71

1.3

1.2

nmol/l

126.1

144.7

1.26

(40768800) Prostate Pathology biopsy report

140

2.59

6.53

1.1

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1101

9715

1.25

6.48

3.8

3.0

u/l

76.8

51.6

4.91

1028

8786

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

137

865

1.62

6.43

3.6

3.4

mmol/l

23.6

24.1

0.96

127

747

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.93

6.43

1.2

1.3

—

(3011412) CD3 cells [#/volume] in Blood

3.22

6.42

1.8

2.2

e9/l

1.4

1.0

0.73

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

253

1825

1.43

6.36

5.5

3.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

357

4581

0.74

6.31

2.8

2.7

ug/l

0.8

0.05

249

3183

(3045788) Cell count panel - Pleural fluid

168

2.40

6.21

1.4

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

5.81

6.10

2.4

2.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.88

5.98

1.3

2.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

229

2.16

5.95

1.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.30

5.86

2.7

2.2

37.4

43.6

—

(3019225) pH of Specimen

245

1789

1.41

5.76

4.5

3.7

—

(3052592) Norovirus Ag [Presence] in Stool

3.92

5.71

1.5

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

577

0.36

5.65

1.4

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.90

5.62

1.4

4.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

133

2.50

5.61

1.2

u/l

52.3

0.00

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.20

5.59

1.6

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

158

2.36

5.57

2.5

3.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.26

5.52

2.9

1.4

—

(3000492) Spirometry study

188

1318

1.46

5.51

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

105

2.69

5.50

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.07

5.49

1.4

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.07

5.49

1.4

1.2

—

(3036489) Thrombin time

496

1.74

5.42

1.7

20.8

21.2

0.37

440

(3027273) Bicarbonate [Moles/volume] in Venous blood

150

1010

1.52

5.37

3.1

2.9

mmol/l

25.5

25.2

0.63

144

970

(3031040) Bacteria [#/volume] in Urine by Automated count

1228

11097

1.22

5.36

5.1

4.5

e6/l

5793.8

2704.7

0.43

195

(3003434) Protein [Mass/volume] in Pleural fluid

246

2.05

5.36

1.4

1.5

g/l

33.5

27.4

2.78

219

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

101

2.69

5.33

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1641

17450

0.81

5.30

19.4

9.3

u/l

26.6

25.7

0.29

1601

16581

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

256

2.01

5.19

1.5

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

259

1947

1.37

5.13

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

184

2.19

5.10

1.3

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

13.37

5.08

1.5

1.2

u/l

7585.4

1112.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

547

0.38

5.06

1.6

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

5.28

5.04

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

167

2342

0.69

5.02

1.2

u/ml

37.4

14.0

0.39

866

(21494814) CD8 cells/100 lymphocytes in Specimen

4.80

5.01

1.4

3.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

105

2.59

4.96

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

339

1.85

4.93

1.6

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

165

1159

1.45

4.82

2.0

1.7

—

(3012441) Differential panel - Pleural fluid

183

2.15

4.75

1.4

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

118

778

1.54

4.69

2.2

1.7

—

(3042631) Mycobacterium sp identified in Specimen

232

2.00

4.65

3.2

2.9

—

(3004451) EKG impression Narrative

2.59

4.63

1.2

—

(3025941) Bacteria identified in Stool by Culture

119

789

1.53

4.61

1.4

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

110

719

1.56

4.55

2.0

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

868

0.53

4.53

1.5

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

488

0.38

4.48

1.7

1.6

e6/l

3010.4

14701.3

5.17

355

(3020891) Body temperature

121

812

1.52

4.45

5.7

4.3

—

(3021589) Normoblasts [#/volume] in Blood

788

6930

1.20

4.27

15.0

8.9

e9/l

0.0

0.75

643

5617

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

346

1.75

4.07

1.5

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

144

1021

1.44

4.04

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

266

1.86

4.04

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

595

1.57

4.02

2.9

2.8

—

(3043409) Potassium [Moles/volume] in Arterial blood

595

1.57

4.02

4.9

4.0

mmol/l

3.8

3.9

1.20

554

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

1.94

3.97

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

362

1.70

3.76

1.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1670

17549

0.84

3.75

36.0

17.8

mmol/l

4.0

11.99

1620

16966

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

170

2.01

3.59

1.4

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

7.79

3.56

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

7.79

3.56

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

7.79

3.56

1.0

—

(40761536) Microorganisms panel - Urine sediment

173

1297

1.36

3.54

3.8

3.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

712

7991

0.84

3.50

2.6

2.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1445

15335

0.85

3.49

31.0

13.5

ml/min/173m2

79.1

73.6

18.22

1292

12360

(3019550) Sodium [Moles/volume] in Serum or Plasma

1669

17504

0.84

3.47

35.9

17.7

mmol/l

138.9

139.7

27.37

1625

16950

(3023183) Ammonium ion [Moles/volume] in Plasma

356

1.67

3.45

1.9

2.4

umol/l

32.3

36.8

0.53

303

(40761511) CBC panel - Blood by Automated count

1603

16860

0.85

3.41

28.6

14.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

138

1004

1.40

3.40

2.7

2.1

g/l

10.1

10.9

1.39

130

907

(3042111) Morphology [Interpretation] in Bone marrow Narrative

238

1.82

3.39

1.5

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

107

2.25

3.38

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

127

2.14

3.35

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

175

2278

0.75

3.35

3.7

4.9

34.6

33.2

0.89

119

1479

(3033705) Calcium.ionized [Moles/volume] in Venous blood

263

1.76

3.27

2.5

2.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.26

3.12

2.1

1.9

u/field

3.4

2.1

0.29

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

515

5891

0.84

3.09

2.2

u/l

315.4

228.2

0.30

482

5486

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

427

0.46

3.08

1.8

1.7

nmol/l

51.4

43.4

0.35

402

(3052851) Hemolysis interference index of Serum or Plasma

495

1.53

3.07

4.3

3.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

7.51

3.05

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.01

3.05

1.0

—

(3003338) MCHC [Mass/volume]

1252

13358

0.87

3.00

41.1

19.1

g/l

327.1

332.2

60.33

1232

13188

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

100

2.21

2.99

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2.24

2.96

1.5

1.8

u/l

455.0

668.6

—

(3000494) Fungus identified in Specimen by Culture

226

1817

1.27

2.84

1.8

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

208

1.79

2.82

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

223

1.76

2.82

1.4

—

(3035880) pH of Pleural fluid

2.23

2.80

1.2

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

2.78

0.0

1.2

—

38.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.32

2.74

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.32

2.74

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

437

3778

1.19

2.73

4.1

ng/l

361.2

515.3

0.32

360

3226

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

196

2440

0.79

2.69

1.3

iu/ml

29.8

40.3

0.47

766

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

175

1372

1.30

2.69

3.8

3.6

ng/l

92.5

97.8

0.35

157

1150

(1002224) Polysomnography panel

457

0.52

2.68

1.0

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

175

1.84

2.68

1.2

1.1

—

(3044941) Cell count panel - Synovial fluid

322

0.43

2.66

1.1

1.4

—

(3003181) Sodium [Moles/volume] in Urine

313

1.61

2.61

1.3

mmol/l

53.1

64.3

1.88

241

(3039443) Prostate specific Ag panel - Serum or Plasma

345

0.46

2.58

1.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.46

2.54

1.8

2.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.46

2.54

1.2

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.17

2.50

1.3

1.4

—

(3051651) Icteric interference index of Serum or Plasma

2.28

2.50

7.6

3.9

—

(4034850)

644

0.61

2.46

13.0

10.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.14

2.44

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

441

0.54

2.42

1.3

1.7

mg/l

7.2

2.9

0.96

322

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.00

2.41

0.0

1.7

—

140.4

—

(3024928) Oxygen saturation in Venous blood

392

1.52

2.41

2.8

—

(3021788) Differential panel - Synovial fluid

348

0.48

2.40

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

760

0.65

2.39

1.2

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

399

0.52

2.37

1.4

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

330

1.56

2.35

1.5

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.26

2.34

1.4

50.7

61.2

0.54

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.38

2.29

1.5

1.4

0.6

2.2

1.45

(3008898) HLA-B27 [Presence]

354

0.50

2.27

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

239

1.64

2.25

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

2.24

0.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

634

1.39

2.22

2.9

1.8

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

179

1.74

2.22

1.3

—

(1616796) Gas panel - Central venous blood

409

1.48

2.20

2.7

3.9

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

150

1.81

2.20

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.29

2.15

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

431

1.45

2.08

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

161

1.75

2.05

2.0

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

124

1575

0.78

2.05

1.4

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

139

1.81

2.05

1.5

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

105

801

1.32

2.03

1.8

1.4

g/l

1.2

1.1

0.05

723

(3043410) Blood group antigens tested for on Red Blood Cells

2.41

2.02

1.3

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

200

1.66

2.02

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

155

1.75

2.00

5.6

3.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

435

1.44

1.99

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

438

1.43

1.93

1.2

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.45

1.93

1.5

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.45

1.93

1.5

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.45

1.93

1.5

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

291

1.52

1.90

1.4

1.9

mmol/l

1.8

0.04

282

(3044242) Glucose [Moles/volume] in Arterial blood

128

1.80

1.89

1.8

1.7

—

(3017732) Neutrophils [#/volume] in Blood

131

1042

1.27

1.88

3.0

3.1

e9/l

4.6

4.2

0.46

714

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

137

1.76

1.83

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

804

7455

1.12

1.82

4.0

4.1

ng/l

48.3

97.0

1.00

656

5700

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.58

1.80

1.6

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

386

1.43

1.79

1.2

1.1

—

1834.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.76

1.79

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

192

1.62

1.77

1.2

iu/l

45.7

28.1

1.47

165

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

201

1.60

1.74

1.1

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

322

0.56

1.74

2.3

1.2

u/l

42.8

21.2

1.07

274

(3037121) Protein [Mass/volume] in Urine

555

1.34

1.66

2.2

2.6

g/l

1.0

0.3

0.50

191

(3001019) Free T4 and TSH panel - Serum or Plasma

389

0.61

1.61

1.6

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

529

0.68

1.56

1.6

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

200

1.56

1.54

1.5

1.8

g/l

0.7

1.0

1.07

154

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.34

1.52

1.2

1.4

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

1.49

0.0

1.0

—

2.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

699

1.28

1.47

2.2

ug/l

260.9

773.3

1.07

655

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.13

1.44

1.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.97

1.43

1.5

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.97

1.43

1.5

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.97

1.43

1.5

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.97

1.43

1.5

1.2

—

(3017569) Oxygen content in Arterial blood

126

1.67

1.40

2.0

1.8

—

(3028433) Virus identified in Specimen by Culture

2.18

1.39

1.0

—

(3011648) Oxygen content in Venous blood

134

1.65

1.39

1.7

1.8

9.2

10.7

0.97

134

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

237

0.55

1.38

1.8

1.5

43.8

66.3

—

155

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

198

1.52

1.37

1.2

1.3

u/ml

103.6

109.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

595

0.72

1.37

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

1.1

—

(3024263) Appearance of Synovial fluid

124

0.40

1.36

1.2

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

1.34

0.0

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.87

1.34

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.87

1.34

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.13

1.33

1.8

2.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

1.32

0.0

1.0

—

0.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

1.32

0.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

168

1.55

1.31

1.4

1.3

nmol/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

525

1.30

4.4

4.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.30

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

137

1.61

1.29

1.0

1.1

u/ml

4.0

3.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

597

1.28

1.3

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

156

1327

1.19

1.26

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

115

1.66

1.24

1.2

u/l

12.1

9.7

0.41

104

(40767503) Oxygen content in Capillary blood by calculation

399

1.34

1.22

2.0

2.5

14.7

16.2

1.15

213

(44806118)

164

1.53

1.20

1.5

1.4

—

(44790048)

164

1.53

1.20

1.5

1.4

—

(44790049)

164

1.53

1.20

1.5

1.4

—

(44790047)

164

1.53

1.20

1.5

1.4

—

(3013512) EKG study

587

5463

1.10

1.20

4.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

1.51

1.17

2.4

2.3

u/field

1.7

0.02

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.78

1.16

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

733

1.24

1.15

1.2

1.4

g/l

3.5

3.9

1.92

519

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.50

1.15

1.4

1.7

umol/l

21.5

16.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

360

1.34

1.15

1.5

1.4

nmol/l

0.7

0.8

1.32

293

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

218

1921

1.15

2.7

3.2

ng/l

271.3

258.0

0.10

202

1765

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

698

1.24

1.14

3.5

3.0

pmol/l

4.2

4.4

1.03

589

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.69

1.13

4.9

4.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1200

11534

1.08

1.13

4.8

4.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

735

1.23

1.13

1.2

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

735

1.23

1.13

1.2

1.4

g/l

7.7

7.5

0.49

536

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

682

1.24

1.11

1.2

1.4

g/l

3.4

3.1

1.29

527

(3037756) Immunofixation for Serum or Plasma

354

1.33

1.10

1.6

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

387

0.69

1.09

1.0

1.2

u/ml

2.0

2.9

—

(3051593) INR in Capillary blood by Coagulation assay

123

0.49

1.05

10.7

12.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.71

1.05

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.96

1.03

1.7

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

220

2465

0.88

1.03

12.7

7.7

—

(3045716) Anion gap in Serum or Plasma

114

1.58

1.02

2.4

1.8

mmol/l

10.2

9.5

0.12

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

157

0.57

0.98

1.1

1.4

—

232.2

—

(3004616) Nuclear Ab [Presence] in Serum

212

0.61

0.98

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

272

0.66

0.97

1.0

1.2

—

47.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

803

0.80

0.97

1.2

u/ml

129.6

250.7

1.53

733

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.95

0.97

1.7

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

417

1.28

0.94

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

417

1.28

0.94

1.5

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.78

0.94

1.7

1.3

nmol/l

0.3

0.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

323

2958

1.11

0.93

23.4

30.4

inr

1.3

1.5

2.50

394

(40765096) Chromosome analysis panel by Banding

2.22

0.93

1.2

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

109

1.56

0.93

1.2

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

221

0.63

0.93

1.0

—

(3005570) Glucose [Moles/volume] in Urine

184

0.60

0.92

1.7

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

196

0.61

0.92

3.3

1.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

0.92

1.5

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.82

0.92

1.5

2.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.63

0.90

1.6

1.4

u/l

4.2

7.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

227

1.37

0.90

1.2

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1383

14216

0.93

0.90

33.3

15.9

35.5

39.1

29.71

869

8858

(21494890) Protein electrophoresis panel - 24 hour Urine

168

1.43

0.89

1.3

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.91

0.88

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.00

0.87

3.0

2.7

u/field

0.8

0.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

378

1.28

0.86

1.5

1.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

273

2490

1.11

0.86

1.5

1.3

g/l

2.6

2.8

0.63

160

1421

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

128

1.49

0.85

1.5

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

128

1.49

0.85

1.5

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

128

1.49

0.85

1.5

1.2

—

(3019150) Specific gravity of Urine by Refractometry

360

3881

0.91

0.85

4.1

kg/l

1.0

0.18

588

(3019977) pH of Arterial blood

112

1.52

0.84

2.4

2.2

7.4

—

(3015183) Erythrocyte sedimentation rate

1.78

0.84

1.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

134

1526

0.87

0.83

2.4

2.2

ug/g

263.5

181.5

1.40

112

1192

(3023420) DNA double strand Ab [Units/volume] in Serum

138

0.58

0.83

1.0

1.3

—

29.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

129

1.48

0.83

1.5

1.4

g/l

3.4

3.0

0.38

(3027135) IgG subclass 1 [Mass/volume] in Serum

129

1.48

0.83

1.5

1.4

g/l

5.4

6.9

1.19

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

488

0.77

0.82

1.5

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

164

0.61

0.80

2.4

1.9

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

114

1.49

0.79

1.4

1.3

u/l

10.7

14.1

2.56

109

(3009214) Lutropin [Units/volume] in Serum or Plasma

233

1.33

0.79

1.6

1.4

u/l

14.4

8.0

1.60

193

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.79

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.79

0.0

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

147

0.61

0.79

1.0

1.1

—

101.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

148

0.61

0.79

1.1

1.7

—

1933.3

—

(3038026) Centromere Ab [Units/volume] in Serum

150

0.60

0.78

1.0

1.1

—

83.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

445

4735

0.93

0.77

3.4

2.6

umol/l

2829.0

6925.5

1.37

380

4000

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.77

0.0

1.3

—

7.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

446

4189

1.08

0.75

3.7

3.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

657

0.82

0.75

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.67

0.74

1.6

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

154

1374

1.13

0.74

4.5

2.4

ml/min/173m2

60.4

62.0

0.19

565

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1076

0.86

0.74

1.9

2.2

nmol/l

14.1

14.9

0.27

924

(3028707) Methadone [Presence] in Urine by Screen method

1.52

0.72

2.6

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.92

0.70

8.2

10.5

mmol/l

4.3

5.6

—

(3037522) Nuclear Ab [Titer] in Serum

175

1931

0.90

0.69

1.2

1.3

titre

520.0

538.2

0.04

445

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.53

0.68

1.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

612

1.18

0.68

1.2

1.5

g/l

0.3

0.5

0.45

518

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

203

0.69

0.67

1.3

1.5

—

(4198724)

1.79

0.66

1.6

—

(3016750) Collection duration of Urine

120

1.42

0.64

1.9

min

508.0

495.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

524

0.82

0.63

1.6

1.5

—

(4062490)

129

1.40

0.63

1.6

1.4

—

(3045414) Leukocytes [Presence] in Urine

729

0.85

0.63

2.5

1.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1202

12322

0.95

0.62

4.3

4.1

mm/h

16.4

13.2

7.86

1104

11272

(3032057) Clostridioides difficile [Presence] in Stool

1.63

0.62

1.7

1.9

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.61

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

290

0.76

0.61

1.8

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

175

0.68

0.60

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.60

0.0

1.2

—

8.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

219

1.28

0.58

1.3

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

115

1284

0.89

0.58

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

0.57

0.56

1.2

1.1

mg/l

84.0

37.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

177

1.30

0.54

1.1

1.4

pmol/l

258.5

287.2

0.32

131

(3006462) Nitrate [Presence] in Urine

1.47

0.54

4.0

3.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.54

0.53

1.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

1.39

0.53

1.1

1.2

mmol/l

8.8

11.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

584

1.15

0.50

1.6

1.5

mg/l

36.2

48.0

0.54

471

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

212

1973

1.08

0.50

2.6

2.4

ug/l

5.6

7.7

1.47

167

1687

(3034860) Kappa light chains.free [Mass/volume] in Serum

585

1.15

0.50

1.7

1.5

mg/l

53.2

50.8

0.11

471

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

1.43

0.49

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.56

0.49

1.0

98.0

94.8

—

(40757373) Influenza virus identified in Isolate

1.49

0.47

1.1

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

599

1.14

0.46

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

129

1.32

0.45

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

246

1.22

0.45

3.0

2.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.59

0.45

2.2

1.2

u/l

749.2

371.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

0.59

0.45

1.0

mg/l

582.6

267.9

—

(4094501)

470

0.85

0.44

1.2

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

1.40

0.44

2.3

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

686

1.13

0.44

1.2

1.4

g/l

9.3

10.4

1.55

573

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.45

0.44

3.0

2.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.37

0.44

1.0

1.4

ug/l

12.1

9.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

166

1.27

0.43

1.0

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

175

1.26

0.43

1.1

—

(3024471) HLA-A [Type]

1.61

0.43

1.0

—

(3024932) HLA-DR beta [Type]

1.61

0.43

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.56

0.42

1.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

131

1.30

0.42

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

295

1.19

0.41

1.4

1.7

iu/l

5.2

3.8

—

(3045424) Erythrocytes [Presence] in Urine

250

0.80

0.41

1.6

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.52

0.41

1.4

1.6

ng/l

225.8

142.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

195

1.23

0.40

1.2

u/ml

328.3

278.3

0.29

121

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.40

0.0

15.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.37

0.40

1.4

2.1

—

(4015189)

1.31

0.39

1.8

2.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

429

1.14

0.38

2.1

2.2

g/l

119.1

131.3

2.20

321

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

188

1.23

0.37

3.9

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

846

8258

1.04

0.37

3.9

3.8

estimate

0.0

1.08

166

1368

(40760888) Immunoglobulin light chains.free panel - Serum

430

1.14

0.37

1.7

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

114

0.70

0.37

1.5

1.1

—

(44806420)

1.39

0.36

2.2

2.4

—

(3029937) Albumin [Presence] in Urine by Test strip

472

4556

1.04

0.36

4.0

estimate

0.0

0.69

153

1356

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

307

2934

1.05

0.35

1.3

1.2

u/ml

1.8

0.02

756

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.66

0.35

1.0

1.4

—

(3048879) Bone marrow aspiration report

1.43

0.35

1.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.40

0.35

1.3

1.4

—

(3047189) Immunofixation for 24 hour Urine

1.37

0.34

1.3

1.1

—

(4146454)

221

0.81

0.33

3.4

2.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

133

0.75

0.33

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

1287

13055

0.97

0.33

38.9

17.2

15.1

13.8

97.20

1262

12660

(3022313) Gas panel - Capillary blood

894

1.09

0.33

2.6

3.6

—

(4211845)

1.31

0.31

4.0

3.7

—

(3011288) Drugs identified in Urine by Screen method

119

1.26

0.31

2.6

2.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

832

8144

1.03

0.31

5.2

5.0

estimate

0.0

0.50

173

1426

(3023410) Appearance of Cerebral spinal fluid

131

0.76

0.31

1.2

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

743

0.91

0.29

1.1

1.2

iu/ml

122.4

125.8

0.02

287

(3044889) 12 lead EKG panel

1176

11928

0.97

0.29

4.9

4.2

—

(3044927) Protein electrophoresis panel - Urine

238

0.84

0.28

1.3

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

251

1.16

0.28

12.0

6.8

mmol/l

6.9

7.7

0.59

203

(3035350) Ketones [Presence] in Urine by Test strip

830

8140

1.03

0.27

3.9

3.7

estimate

0.0

0.00

173

1419

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

585

1.10

0.27

1.2

1.4

g/l

35.6

37.2

1.13

482

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.25

0.27

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

119

0.76

0.27

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.67

0.25

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.25

1.7

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

154

1462

1.06

0.25

1.6

1.7

1.6

0.32

125

1241

(40768443) Skin Pathology biopsy report

618

1.09

0.24

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

255

0.86

0.24

1.2

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

198

1.16

0.24

2.0

3.1

mg/l

14.7

29.0

0.68

155

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

548

0.91

0.24

2.4

2.2

ug/min

220.5

96.2

0.53

326

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

115

1.22

0.23

1.3

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

106

1.23

0.23

1.3

1.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

162

1.17

0.22

1.1

117.4

113.1

0.26

148

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

247

1.13

0.22

1.6

2.2

mg/l

40.0

24.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.25

0.22

2.0

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.25

0.22

1.0

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

284

0.88

0.22

2.6

3.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.9

—

23.3

—

(3022621) pH of Urine by Test strip

112

1181

0.95

0.21

3.3

3.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

177

0.85

0.21

1.1

1.7

—

25.8

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

330.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

43.7

—

(4212803)

0.00

0.21

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.22

0.20

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

114

0.79

0.20

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

193

1.14

0.19

1.6

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

213

1.13

0.18

1.2

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1653

16416

1.02

0.18

30.9

14.6

mg/l

37.1

26.1

28.27

1521

13100

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

184

0.87

0.17

1.0

1.1

—

18.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.76

0.17

1.0

1.1

—

(3009343) pH of Capillary blood

128

1228

1.04

0.16

2.6

3.5

7.4

0.20

152

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.79

0.15

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

284

1.09

0.15

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

112

1.16

0.14

1.5

1.2

—

(3021901) Oxygen saturation in Capillary blood

382

1.07

0.14

2.6

2.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.83

0.13

1.9

1.8

—

(4306422)

170

1.12

0.13

1.1

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

396

4027

0.98

0.13

3.6

3.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

325

1.08

0.13

1.1

—

(4024509)

180

1.11

0.13

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.17

0.13

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

395

0.94

0.12

2.9

2.3

—

(3016018) Differential panel - Cerebral spinal fluid

137

0.88

0.12

1.2

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

162

1.11

0.11

1.0

1.1

—

(3000330) Specific gravity of Urine by Test strip

102

985

1.04

0.11

5.0

3.6

—

(21494434) Karyotype in Bone marrow

146

0.89

0.10

1.0

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

166

0.90

0.09

1.0

1.2

—

47.2

—

(40762814) Titanium [Mass/volume] in Blood

1.11

0.09

2.2

—

3.1

—

(3000012) Reticulocyte production index

106

1.13

0.09

1.2

1.6

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

639

6327

1.01

0.09

3.0

3.2

ng/l

1883.0

1858.8

0.04

579

5450

(4010399)

115

1182

0.97

0.09

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.15

0.09

1.7

1.6

nmol/l

16.2

16.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

253

1.07

0.08

3.8

4.0

umol/l

356.1

339.4

0.20

213

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

107

1.12

0.08

2.1

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

144

0.90

0.08

2.5

1.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

144

0.90

0.08

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.03

0.08

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

175

1.09

0.08

2.2

2.3

586.5

620.1

0.12

108

(21491868) Cryoglobulin [Mass/volume] in Serum

0.83

0.08

1.2

1.3

g/l

—

0.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

128

1250

1.03

0.08

2.6

3.5

kpa

5.2

0.09

120

1140

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.77

0.08

1.2

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.06

0.08

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

256

0.94

0.08

1.6

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.03

0.07

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

0.86

0.07

1.7

1.6

—

12.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

638

6333

1.01

0.07

4.1

4.0

—

(3000764) Benzodiazepines [Presence] in Urine

177

1.07

0.06

2.2

1.8

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

0.89

0.06

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

101

0.89

0.06

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

101

0.89

0.06

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

104

0.86

0.06

1.0

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

104

0.86

0.06

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

104

0.86

0.06

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

355

1.04

0.06

1.0

1.1

u/ml

2.7

13.2

—

(3027008) Opiates [Presence] in Urine

178

1.07

0.05

2.2

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

160

1622

0.99

0.05

1.3

—

(3016879) Cocaine [Presence] in Urine

171

0.93

0.05

2.4

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

169

1.07

0.05

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

317

1.04

0.05

1.3

1.4

—

(3028300) Cannabinoids [Presence] in Urine

179

1.06

0.04

2.3

1.8

—

(36660697) Celiac disease serology panel - Serum

103

1048

0.98

0.04

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

635

1.02

0.04

1.5

1.8

u/l

39.8

38.4

0.19

526

(3014271) Vancomycin [Susceptibility]

121

1.07

0.03

2.8

3.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

129

0.93

0.03

1.1

1.2

88.1

93.1

0.33

122

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

451

0.97

0.03

1.4

1.6

iu/ml

0.0

6.7

0.56

100

(3035320) C reactive protein [Mass/volume] in Body fluid

108

0.93

0.03

2.3

2.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

269

0.97

0.02

1.0

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

132

1.06

0.02

1.4

1.7

—

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

500

1.02

0.02

3.0

3.2

nmol/l

1.0

0.8

1.94

375

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

120

1188

1.01

0.02

2.6

3.5

mmol/l

1.8

2.0

0.19

847

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

343

3439

1.00

0.01

1.6

mg/l

2.1

1.4

2.60

282

2651

(3047007) Chlamydophila sp Ab [Presence] in Serum

156

0.96

0.00

1.1

1.3

—

(4268621)

124

1.05

0.00

2.2

2.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

226

0.97

0.00

1.6

1.5

—

(3017704) Immunofixation for Urine

105

1.05

0.00

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

334

0.99

0.00

1.4

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

745

1.01

0.00

2.6

3.9

mmol/l

25.1

24.8

0.30

671

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

173

0.98

0.00

1.2

u/ml

2.3

6.4

1.96

(3027944) Amphetamines [Presence] in Urine

176

1.02

0.00

2.3

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

301

1.00

0.00

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

533

0.99

0.00

3.3

3.1

mmol/l

23.9

25.0

1.23

470

(40761535) Cells panel - Urine sediment

158

1577

1.00

0.00

3.1

3.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

432

0.99

0.00

3.5

3.4

mg/l

41.6

29.9

0.94

294

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

186

1.02

0.00

1.2

u/ml

1.6

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

384

0.99

0.00

1.3

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.98

0.00

1.0

—

4.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.88

0.00

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.95

0.00

1.0

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.0

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

5.8

—

21.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.01

0.00

1.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.01

0.00

1.0

1.3

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.93

0.00

3.6

7.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.94

0.00

1.5

2.3

u/ml

2102.3

1071.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.02

0.00

3.6

7.8

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

2.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.4

—

2.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.0

1.8

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

6.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

7.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

7.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.89

0.00

1.2

1.6

ug/l

4.9

12.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_STOMACH_EXALLC – Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers) (C3_STOMACH_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints